[go: up one dir, main page]

Kirkpatrick, 1988 - Google Patents

Transfer factor

Kirkpatrick, 1988

View PDF
Document ID
14366670785104350741
Author
Kirkpatrick C
Publication year
Publication venue
Journal of Allergy and Clinical Immunology

External Links

Snippet

It has been more than 30 years since Dr. HS Lawrence first reported that it was possible to transfer delayed-type hypersensitivity from sensitized donors to unsensitized recipients with lysates of blood leukocytes. During recent years, research from several laboratories has …
Continue reading at www.jacionline.org (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from micro-organisms
    • Y10S530/826Viruses

Similar Documents

Publication Publication Date Title
Kirkpatrick Transfer factor
US6083919A (en) Materials and methods for treating autoimmune disease
Kirkpatrick Transfer factors: identification of conserved sequences in transfer factor molecules
Pircher et al. Lower receptor avidity required for thymic clonal deletion than for effector T-cell function
US4803072A (en) Immunomodulation
Rasmussen et al. Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans.
Engers et al. Inhibition of T cell-mediated functions by MVM (i), a parvovirus closely related to minute virus of mice.
Germain et al. Antigen-specific T-cell-mediated suppression. I. Induction of L-glutamic acid (60)-L-alanine (30)-L-tyrosine (10) specific suppressor T cells in vitro requires both antigen-specific T-cell-suppressor factor and antigen
Zuckerman et al. Immunologic specificity of transfer factor
Wecker et al. Expression of MuLV GP71-like antigen in normal mouse spleen cells induced by antigenic stimulation
Sun et al. Suppression of antigen-specific T cell proliferation by measles virus infection: role of a soluble factor in suppression
DeFreitas et al. Human T-lymphocyte response in vitro to synthetic peptides of herpes simplex virus glycoprotein D.
Hughes et al. Immunopotentiation of bovine herpes virus subunit vaccination by interleukin-2
Hiramatsu et al. Unique T cell Ia antigen expressed on a hybrid cell line producing antigen-specific augmenting T cell factor.
Härfast et al. Immunoglobulin-independent natural cytotoxicity of Fc receptor-bearing human blood lymphocytes to mumps virus-infected target cells
Lutz et al. Accessory cell requirements for the generation of cytolytic T lymphocytes
Yoshida et al. Biologic and antigenic similarity of virus-induced migration inhibition factor to conventional, lymphocyte-derived migration inhibition factor.
Handzel et al. Immunomodulation of T cell deficiency in humans by thymic humoral factor: From crude extract to synthetic thymic humoral factor-γ2
Warren et al. Antigen mediation of a late-acting suppressor T-cell activity.
Chu et al. Examining the immune response in sentinel lymph nodes of mice and men
Yodoi et al. Formation of IgE-binding factors by rat T lymphocytes. I. Induction of IgE-binding factors by poly I: C and interferon.
Friedman et al. MLC-derived human helper factor (s) that promote B cell differentiation: induction, functional characterization, and role of Ia antigens.
Hirashima et al. The mediation of tissue eosinophilia in hypersensitivity reactions. IV. Production of delayed eosinophil chemotactic factor-A by peritoneal exudate cells from sensitized guinea-pigs in vitro
US5565549A (en) CD8+ cell antiviral factor
Neu The role of cellular and humoral factors in infections